Pfizer, Merck KGaA's Bavencio takes a hit with second ovarian cancer failure

Back in November, Pfizer and Merck KGaA reported that immuno-oncology drug Bavencio had failed a late-stage ovarian cancer trial. And now the companies can make it two. Friday, the partners said they’d scrapped a phase 3 study examining Bavencio in combination with and/or after chemo in previously untreated patients after the drug showed it couldn’t… Read More »

13 Best Foods to Cleanse Your Colon

Healthy Eating Jessica MigalaDec 25 Not only will these foods help protect your gut—they all happen to be delicious and nutritious additions to your diet. Check out these wonderful foods that cleanse your colon. What does your colon do, anyway? LightField Studios/Shutterstock Though your small intestine does the heavy lifting when it comes to digesting… Read More »

U.S. drug developer Capricor places Duchenne drug trial on hold

(Reuters) – Capricor Therapeutics Inc said on Wednesday it had put on hold a clinical trial of its drug to treat Duchenne muscular dystrophy (DMD), a muscle-wasting disorder, citing a safety review. The review follows a severe allergic reaction during infusion of the drug, the company said in a filing here. The patient responded well… Read More »